# Efficacy of Sialic Acid GNE Related Thrombocytopenia

> **NCT02845609** · PHASE2 · COMPLETED · sponsor: **Hadassah Medical Organization** · enrollment: 5 (actual)

## Conditions studied

- Thrombocytopenia

## Interventions

- **DRUG:** Sialic Acid-Extended Release

## Key facts

- **NCT ID:** NCT02845609
- **Lead sponsor:** Hadassah Medical Organization
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09
- **Primary completion:** 2017-09
- **Final completion:** 2017-09
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2018-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02845609

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02845609, "Efficacy of Sialic Acid GNE Related Thrombocytopenia". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT02845609. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*